Ignite Creation Date:
2024-05-06 @ 7:39 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02573220
Status:
WITHDRAWN
Last Update Posted:
2016-12-09
First Post:
2015-09-21
Brief Title:
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer
Sponsor:
University of Chicago
Organization:
University of Chicago
Organization Data
Organization:
University of Chicago
Class:
OTHER
Study ID:
IRB15-0081
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Chicago
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |